Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
How does bedaquiline kill drug-resistant Mycobacterium tuberculosis? A structural investigation with electron cryomicroscopy
EF 2018-19
Résumé
Tuberculosis (TB) is one of the top ten causes of death worldwide, in Canada largely affecting foreign-born individuals and Canadian-born Indigenous peoples. TB is caused by the bacterium Mycobacterium tuberculosis, and, like many bacterial infections, can become resistant to antibiotics. A drug approved by the U.S. Food and Drug Administration in 2012 called bedaquiline (also known as Sirturo), although still requiring long treatment regimens with major side effects, has been shown to be part of an effective treatment strategy for extensively drug-resistant TB. While it is known that the drug affects M. tuberculosis’ ATP synthase, the enzyme that makes ATP (the cell’s energy source), it is unclear how the drug affects this enzyme. It is also unknown why bedaquiline inhibits other bacterial ATP synthases, but kills M. tuberculosis and its close relatives specifically. Electron cryomicroscopy (cryoEM) can permit us to determine the structure of the bacterium’s ATP synthase with bedaquline bound to it with atomic-level resolution. Knowledge of the structure will enable us to understand how the drug works, and how it is able to sterilize a M. tuberculosis infection. This information can be used to develop more effective and faster treatments for TB with fewer side effects.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
406290
Name
Keon Kristine A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
How does bedaquiline kill drug-resistant Mycobacterium tuberculosis? A structural investigation with electron cryomicroscopy
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Atp Synthase; Bedaquiline; Biochemistry; Cryoem; Drug Mechanism; Electron Transport Chain; Metabolism; Mycobacterium Tuberculosis; Structural Biology; Tuberculosis
Abstract
Tuberculosis (TB) is one of the top ten causes of death worldwide, in Canada largely affecting foreign-born individuals and Canadian-born Indigenous peoples. TB is caused by the bacterium Mycobacterium tuberculosis, and, like many bacterial infections, can become resistant to antibiotics. A drug approved by the U.S. Food and Drug Administration in 2012 called bedaquiline (also known as Sirturo), although still requiring long treatment regimens with major side effects, has been shown to be part of an effective treatment strategy for extensively drug-resistant TB. While it is known that the drug affects M. tuberculosis’ ATP synthase, the enzyme that makes ATP (the cell’s energy source), it is unclear how the drug affects this enzyme. It is also unknown why bedaquiline inhibits other bacterial ATP synthases, but kills M. tuberculosis and its close relatives specifically. Electron cryomicroscopy (cryoEM) can permit us to determine the structure of the bacterium’s ATP synthase with bedaquline bound to it with atomic-level resolution. Knowledge of the structure will enable us to understand how the drug works, and how it is able to sterilize a M. tuberculosis infection. This information can be used to develop more effective and faster treatments for TB with fewer side effects.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Keon, Kristine A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~